US-based telehealth solutions company Ostar Healthcare Technology has introduced its cellular telehealth blood pressure monitoring system.
Launched in North American market, Ostar Cellular P201 Remote TeleHealth Blood Pressure Gateway System will help in reduction of 30 day readmission rates for heart patients, specifically Congestive Heart Failure (CHF).
Ostar Healthcare Technology CEO Doug Hemenway said: "This North American launch of Ostar Cellular P201 brings forth another market first, a unique cell enabled health device with a combined data gateway approach.
"All Ostar products reinforce Ostar’s commitment to advanced remote monitoring, reducing 30 Day Readmission Rates, in line with (CMS) edicts, improving patient outcomes, avoiding unnecessary costs, as required by Accountable Care Act (PPACA)."
The monitoring system includes cellular device with combined mHealth Personal Dashboard app, which transmits relevant data to population health management systems, wellness platforms, EMR’s and HIE’s across the globe.
Ostar noted that the P201 Remote Cellular TeleHealth Blood Pressure Gateway System is the first Cellular P Series to be released.
Ostar Healthcare Technology COO Paul Markham said: "Given the current transformation of healthcare in the US, this simple cellular enabled, insurance card enabled, remote teleHealth solution, has the potential to positively impact advanced chronic disease management outcomes."
Image: Ostar Healthcare has launched P201 Remote TeleHealth Blood Pressure Gateway System. Photo: courtesy of PRNewswire/ Ostar Healthcare Technology.